PGxCare provides an AI-powered pharmacogenetics platform that analyzes genetic data to deliver personalized drug therapy recommendations. This technology ensures safe and effective treatment by identifying optimal medications and potential drug interactions based on individual genetic profiles.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current pharmacogenetic testing methods can be costly and time-consuming, hindering the widespread adoption of personalized drug therapy. Many healthcare providers lack the tools to efficiently analyze genetic data and translate it into actionable prescribing decisions, potentially leading to suboptimal medication choices and adverse drug reactions.
Solution
PGxCare offers an AI-powered platform that streamlines pharmacogenetic data analysis, providing clinicians with personalized drug therapy recommendations. The platform analyzes a patient's genetic profile to identify optimal medications, predict potential drug interactions, and assess individual risk factors. By leveraging AI algorithms and a comprehensive drug database, PGxCare enables healthcare providers to make informed decisions, improve treatment outcomes, and reduce healthcare costs. The platform's holistic drug interaction analysis identifies potential risks associated with combined medication intake and can pinpoint health risks such as thrombosis and atherosclerosis.
Target Audience
The primary target audience includes healthcare providers, such as physicians, pharmacists, and clinical researchers, seeking to implement personalized medicine strategies and optimize drug therapy for their patients.
Features
- AI-powered analysis of pharmacogenetic data for rapid and accurate results
- Extensive drug database encompassing over 730 medications across all clinical specialties
- Cost-effective analysis at approximately $0.055 per drug analysis
- Holistic drug interaction analysis identifying potential risks associated with combined medication intake
- Identification of health risks such as thrombosis and atherosclerosis
- Advanced AI algorithms for pharmacogenetic data analysis
- Neural networks for data processing
- Feature importance analysis
- Report generation